BHC Bausch Health Companies Inc
- Stocks
- Healthcare
- NYSE: BHC
Price (delayed)
$6.78
Market cap
$2.51B
P/E Ratio
6.99
Dividend/share
N/A
EPS
$0.97
Enterprise value
$22.21B
Relative Growth:
Rel. Growth:
69
Relative Strength:
Rel. Strength:
56
Relative Valuation:
Rel. Valuation:
99
Relative Profitability:
Rel. Profitability:
68
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of
Highlights
The company's equity has surged by 52% YoY and by 26% QoQ
Bausch Health Companies's quick ratio has increased by 24% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.bauschhealth.com
Key stats
What are the main financial stats of BHC
Market
Valuations
Earnings
Shares outstanding
370.52M
Market cap
$2.51B
Enterprise value
$22.21B
Price to earnings (P/E)
6.99
Price to book (P/B)
N/A
Price to sales (P/S)
0.25
PEG
0.02
EV/EBIT
10.55
EV/EBITDA
6.67
EV/Sales
2.21
Revenue
$10.03B
Gross profit
$7.09B
Operating income
$1.9B
Net income
$362M
EBIT
$2.11B
EBITDA
$3.33B
Free cash flow
$1.08B
Per share
Balance sheet
Liquidity
EPS
$0.97
EPS diluted
$0.97
Free cash flow per share
$2.92
Book value per share
-$1.53
Revenue per share
$27.01
TBVPS
$28.84
Total assets
$26.82B
Total liabilities
$26.47B
Debt
$21.04B
Equity
-$565M
Working capital
$1.46B
Debt to equity
-37.24
Current ratio
1.3
Quick ratio
0.78
Net debt/EBITDA
5.92
Margins
Efficiency
Dividend
EBITDA margin
33.2%
Gross margin
70.7%
Net margin
3.6%
Operating margin
18.9%
Return on assets
1.4%
Return on equity
N/A
Return on invested capital
8.3%
Return on capital employed
9.6%
Return on sales
21%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BHC stock price
How has the Bausch Health Companies stock price performed over time
Intraday
0.59%
1 week
14.92%
1 month
1.5%
1 year
-30.03%
YTD
-15.88%
QTD
5.12%
Financial performance
How have Bausch Health Companies's revenue and profit performed over time
Revenue
$10.03B
Gross profit
$7.09B
Operating income
$1.9B
Net income
$362M
Gross margin
70.7%
Net margin
3.6%
The company's operating income rose by 41% YoY and by 19% QoQ
The operating margin has grown by 33% YoY and by 17% from the previous quarter
BHC's gross profit is up by 6% year-on-year
The revenue has increased by 6% year-on-year
Price vs fundamentals
How does BHC's price correlate with its fundamentals
Growth
What is Bausch Health Companies's growth rate over time
Valuation
What is Bausch Health Companies stock price valuation
P/E
6.99
P/B
N/A
P/S
0.25
EV/EBIT
10.55
EV/EBITDA
6.67
EV/Sales
2.21
The company's equity has surged by 52% YoY and by 26% QoQ
The price to sales (P/S) is 58% lower than the 5-year quarterly average of 0.6 and 17% lower than the last 4 quarters average of 0.3
The revenue has increased by 6% year-on-year
Efficiency
How efficient is Bausch Health Companies business performance
BHC's return on invested capital has surged by 57% year-on-year and by 17% since the previous quarter
BHC's return on sales is up by 42% year-on-year and by 14% since the previous quarter
Dividends
What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BHC.
Financial health
How did Bausch Health Companies financials performed over time
Bausch Health Companies's quick ratio has increased by 24% YoY
The current ratio has grown by 9% YoY
The debt to equity has dropped by 103% year-on-year and by 31% since the previous quarter
The company's equity has surged by 52% YoY and by 26% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.